OLD National Bancorp IN decreased its holdings in Clorox Co (NYSE:CLX) by 2.9% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 21,646 shares of the company’s stock after selling 637 shares during the period. OLD National Bancorp IN’s holdings in Clorox were worth $3,314,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also modified their holdings of the company. Mn Services Vermogensbeheer B.V. grew its holdings in Clorox by 0.6% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 70,968 shares of the company’s stock worth $11,388,000 after purchasing an additional 400 shares during the last quarter. Deutsche Bank AG grew its holdings in shares of Clorox by 10.2% during the fourth quarter. Deutsche Bank AG now owns 307,703 shares of the company’s stock valued at $47,425,000 after buying an additional 28,361 shares during the last quarter. SlateStone Wealth LLC grew its holdings in shares of Clorox by 13.6% during the first quarter. SlateStone Wealth LLC now owns 5,043 shares of the company’s stock valued at $809,000 after buying an additional 605 shares during the last quarter. Montecito Bank & Trust grew its holdings in shares of Clorox by 24.0% during the first quarter. Montecito Bank & Trust now owns 5,212 shares of the company’s stock valued at $836,000 after buying an additional 1,009 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC grew its holdings in shares of Clorox by 1.1% during the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 35,017 shares of the company’s stock valued at $5,619,000 after buying an additional 384 shares during the last quarter. 76.83% of the stock is owned by institutional investors.
A number of equities research analysts have recently weighed in on CLX shares. Bank of America reissued a “neutral” rating and set a $154.00 price objective (down from $165.00) on shares of Clorox in a report on Thursday, May 2nd. Citigroup set a $156.00 price target on shares of Clorox and gave the company a “hold” rating in a report on Thursday, May 23rd. ValuEngine lowered shares of Clorox from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Wells Fargo & Co reaffirmed a “hold” rating and issued a $153.00 price target on shares of Clorox in a report on Thursday, August 1st. Finally, Morgan Stanley upped their price target on shares of Clorox from $141.00 to $144.00 and gave the company an “underweight” rating in a report on Friday, August 2nd. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company. Clorox has a consensus rating of “Hold” and an average target price of $154.07.
Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The business had revenue of $1.63 billion during the quarter, compared to the consensus estimate of $1.69 billion. During the same quarter in the prior year, the firm posted $1.66 earnings per share. The company’s revenue was down 3.8% compared to the same quarter last year. As a group, sell-side analysts expect that Clorox Co will post 6.4 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, August 16th. Investors of record on Wednesday, July 31st will be given a dividend of $1.06 per share. This represents a $4.24 annualized dividend and a dividend yield of 2.67%. The ex-dividend date of this dividend is Tuesday, July 30th. This is an increase from Clorox’s previous quarterly dividend of $0.96. Clorox’s dividend payout ratio is 67.09%.
In other Clorox news, SVP Diego J. Barral sold 1,987 shares of the stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $157.59, for a total value of $313,131.33. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director A D. David Mackay sold 3,400 shares of the stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $154.87, for a total transaction of $526,558.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 25,786 shares of company stock valued at $4,054,776. Insiders own 1.40% of the company’s stock.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
See Also: What is the Russell 2000 Index?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.